Status:
RECRUITING
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
Lead Sponsor:
Columbia University
Conditions:
COVID-19
Corona Virus Infection
Eligibility:
All Genders
7+ years
Brief Summary
The 2019-2020 COVID-19 pandemic is the largest outbreak in recent history. It is not known how long after someone gets sick with COVID-19 and recovers that they can still infect other people. It is al...
Detailed Description
This is an observational prospective cohort study of confirmed cases of COVID-19 recruited from communities surrounding New York City. 325 participants will be recruited from NewYork-Presbyterian (NYP...
Eligibility Criteria
Inclusion
- Laboratory confirmed SARS-CoV-2 using currently available laboratory testing techniques (e.g.,RT-PCR, Immunoglobulin M (IgM) /IgG) or clinical history compatible with a COVID-19 like illness(fever, cough, shortness of breath).
- Negative participants with no known prior COVID-19 diagnosis or COVID vaccine
- At least 7 years of age
- Participants are eligible to provide semen and breast milk samples if they are 18 years of age or older
Exclusion
- Age \<7
- Intercurrent conditions that in the opinion of the investigator would confound the findings of the study.
Key Trial Info
Start Date :
March 26 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04448145
Start Date
March 26 2020
End Date
September 1 2026
Last Update
November 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032